Related Experiment Video
Updated: May 27, 2026
Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
Quantitative relationships between transforming growth factor beta mRNA isoforms in congenital and traumatic
Pawel Banasiak1, Barbara Strzalka-Mrozik, Maria Forminska-Kapuscik
1Division of Pediatric Ophthalmology, Department of Ophthalmology, Medical University of Silesia, Katowice, Poland. pawel.banasiak@gmail.com
Insights
Transforming growth factor-beta (TGFβ) isoforms showed different expression in blood cells of children with congenital cataracts compared to traumatic cataracts. This suggests TGFβ1 and TGFβ2 may play a role in congenital lens opacity development.
Area of Science:
- Ophthalmology
- Molecular Biology
- Pediatric Medicine
Background:
- Cataracts are a leading cause of childhood blindness.
- Understanding the molecular mechanisms of congenital and traumatic cataracts is crucial for developing targeted therapies.
- Transforming growth factor-beta (TGFβ) signaling pathways are implicated in various ocular conditions.
Purpose of the Study:
- To investigate differences in the expression profiles of TGFβ isoforms (TGFβ1, TGFβ2, TGFβ3) in anterior lens capsules (ALCs) and peripheral blood mononuclear cells (PBMCs).
- To compare these expression profiles between pediatric patients with congenital cataracts and traumatic cataracts.
Main Methods:
- Real-time quantitative reverse transcription (QRT)-PCR was used to quantify TGFβ1, TGFβ2, and TGFβ3 mRNA expression.
- Samples included ALC fragments from cataract surgery and whole blood from 40 children with congenital cataracts and 22 with traumatic cataracts.
- SYBR Green I chemistry was employed for mRNA quantification.
Main Results:
- TGFβ1, TGFβ2, and TGFβ3 mRNA were detected in all analyzed samples (ALCs and PBMCs).
- Significant differences in TGFβ1 and TGFβ2 expression profiles were observed in PBMCs between congenital and traumatic cataract groups.
- No significant differences in TGFβ isoform expression were found in the ALC samples between the two groups.
Conclusions:
- Overexpression of TGFβ1 and TGFβ2 in PBMCs of children with congenital cataracts suggests their potential involvement in the pathogenesis of lens opacity.
- These findings highlight distinct molecular differences in the systemic response to congenital versus traumatic cataracts.
- Further research into TGFβ signaling could offer novel therapeutic targets for congenital cataracts.
Purpose:
The aim of this study was to determine differences in the expression profiles of transforming growth factor (TGF) β isoforms in the fragments of anterior lens capsules (ALCs) and peripheral blood mononuclear cells (PBMCs) of pediatric patients with congenital and traumatic cataracts.
Methods:
Forty children with congenital cataracts (19 girls and 21 boys) and 22 children with traumatic cataracts (six girls and 16 boys) participated in the study. Fragments of ALCs obtained during cataract surgery and whole blood samples were analyzed. Quantification of TGFβ1, TGFβ2, and TGFβ3 mRNA was performed by real-time quantitative reverse transcription (QRT)-PCR using SYBR Green I chemistry.
Results:
TGFβ1, TGFβ2, and TGFβ3 mRNA was detected in all the studied samples. Significant differences were found for TGFβ1 and TGFβ2 expression profiles in PBMCs between the patients with congenital and traumatic cataracts. The expression profiles of TGFβ isoforms in ALCs did not differ significantly between the groups.
Conclusions:
Overexpression of TGFβ1 and TGFβ2 in the PBMCs of patients with congenital cataracts might indicate that these cytokines are involved in the development of lens opacity.
